Candriam S.C.A. - TETRAPHASE PHARMACEUTICALS I ownership

TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 95 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q3 2017. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.

Quarter-by-quarter ownership
Candriam S.C.A. ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q2 2019$7,000
-66.7%
15,6130.0%0.00%
Q1 2019$21,000
+16.7%
15,6130.0%0.00%
Q4 2018$18,000
-58.1%
15,6130.0%0.00%
-100.0%
Q3 2018$43,000
-97.6%
15,613
-96.8%
0.00%
-96.4%
Q2 2018$1,769,000
+10.7%
495,613
-4.8%
0.03%
+3.7%
Q1 2018$1,598,000
-49.8%
520,613
+3.1%
0.03%
-50.9%
Q4 2017$3,182,000
+18.4%
505,000
+28.5%
0.06%
+17.0%
Q3 2017$2,688,000
+87.6%
393,000
+95.5%
0.05%
+74.1%
Q2 2017$1,433,000
-22.4%
201,0000.0%0.03%
-25.0%
Q1 2017$1,847,000
+22.6%
201,000
-46.3%
0.04%
+2.9%
Q4 2016$1,507,000
+5.2%
374,0000.0%0.04%
+2.9%
Q3 2016$1,432,000
-10.9%
374,0000.0%0.03%
-19.0%
Q2 2016$1,608,000
+22.9%
374,000
+31.7%
0.04%
+27.3%
Q1 2016$1,308,000
-38.9%
284,000
+33.0%
0.03%
-42.1%
Q4 2015$2,142,000
+164.4%
213,600
+96.7%
0.06%
+185.0%
Q3 2015$810,000
-88.1%
108,600
-24.1%
0.02%
-85.8%
Q2 2015$6,784,000
+50.5%
143,000
+16.3%
0.14%
+54.9%
Q1 2015$4,508,000
+106.4%
123,000
+123.6%
0.09%
+97.8%
Q4 2014$2,184,00055,0000.05%
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q3 2017
NameSharesValueWeighting ↓
HARVEY CAPITAL MANAGEMENT INC 293,675$14,061,0004.76%
BB BIOTECH AG 1,507,114$71,497,0001.94%
SECTORAL ASSET MANAGEMENT INC 893,076$42,368,0001.77%
Opaleye Management Inc. 65,000$3,084,0001.23%
COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT 390,294$18,515,0001.14%
Granite Point Capital Management, L.P. 75,206$3,568,0001.04%
Granahan Investment Management 705,601$33,474,0000.95%
Iguana Healthcare Management, LLC 50,000$2,372,0000.75%
Eventide Asset Management 290,000$13,758,0000.74%
Rhenman & Partners Asset Management AB 107,400$5,095,0000.61%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders